Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Efficacy and Safety of Alirocumab in Individuals with Diabetes Mellitus: Pooled Analyses from Five Placebo-Controlled Phase 3 Studies.

Henry N. Ginsberg,Michel Farnier,Jennifer G. Robinson,Christopher P. Cannon,Naveed Sattar,Marie T. Baccara-Dinet,Alexia Letierce,Maja Bujas-Bobanovic,Michael J. Louie,Helen M. Colhoun

Diabetes Therapy（2018）

Cited 19|Views12
No score
Abstract
Diabetes mellitus (DM) carries an elevated risk for cardiovascular disease. Here, we assessed alirocumab efficacy and safety in people with/without DM from five placebo-controlled phase 3 studies.
More
Translated text
Key words
Alirocumab,Cholesterol-lowering drugs,Diabetes mellitus,LDL-C,PCSK9
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined